Ubs Global Asset Management Americas »

Inhibrx shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Inhibrx (INBX) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Inhibrx

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.2M 32k 38.00
2023-09-30 $591k 32k 18.35
2022-12-31 $435k 18k 24.64
2022-06-30 $114k 10k 11.35

More positions owned by Ubs Global Asset Management Americas

Microsoft Corp Equity Us Cm (MSFT)
Apple Equity Us Cm (AAPL)
Amazon Equity Us Cm (AMZN)
Nvidia Corp Equity Us Cm (NVDA)
Alphabet Inc Cl A Equity Us Cm (GOOGL)
Tesla Equity Us Cm (TSLA)
Meta Platforms Equity Us Cm (META)
Alphabet Inc Cl C Equity Us Cm (GOOG)
Unitedhealth Group Equity Us Cm (UNH)
Broadcom Equity Us Cm (AVGO)
Adobe Equity Us Cm (ADBE)
Eli Lilly &#38 Equity Us Cm (LLY)
Visa Inc Class A Shares Equity Us Cm (V)
Home Depot Equity Us Cm (HD)
Johnson &#38 Johnson Equity Us Cm (JNJ)

View all positions for Ubs Global Asset Management Americas

Top funds holding Inhibrx

Viking Global Investors
RA Capital Management
Perceptive Advisors
Vanguard Group
Arrowpoint Asset Management
Bank of America Corporation
Logos Global Management
Partner Fund Management
Russell Investments
Citadel Advisors
Caption Management
Millennium Management
Charles Schwab Investment Management
Sphera Funds Management
Two Sigma Advisers

View all funds holding Inhibrx